Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 90/100

Failure Rate

33.3%

2 terminated/withdrawn out of 6 trials

Success Rate

66.7%

-19.8% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 4 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
4(66.7%)
Early Phase 1
1(16.7%)
Phase 1
1(16.7%)
6Total
N/A(4)
Early Phase 1(1)
Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT06712381Phase 1Completed

Carac & PDT Combination in the Treatment Of Actinic Keratoses

Role: lead

NCT03508869Not ApplicableTerminated

Mirvaso® Gel and Dysport® for Erythema and Flushing of Rosacea

Role: lead

NCT03508973Not ApplicableCompleted

Sculptra for Décolletage Crepiness and Wrinkling

Role: lead

NCT03508856Not ApplicableCompleted

Clinical and Histologic Evaluation of Picato 0.15% Gel in the Cosmetic Improvement of Photoaged Skin

Role: lead

NCT02780258Not ApplicableCompleted

Restylane Silk for Photoaged Thinned Hands

Role: lead

NCT03106766Early Phase 1Terminated

Six Months Evaluation of Next Science Acne Creams on Facial Acne in Adult Females.

Role: collaborator

All 6 trials loaded